10-acetylirciformonin B, A sponge furanoterpenoid, induces dna damage and apoptosis in leukemia cells

Molecules

Volumn 17, Issue 10, 2012, Pages 11839-11848

  Su, Jui Hsin ^a,b   Chang, Wen Been ^a,b   Chen, Huei Mei ^c   El Shazly, Mohamed ^d,e   Du, Ying Chi ^d   Kung, Ting Hsuan ^a   Chen, Yu Cheng ^a   Sung, Ping Jyun ^a,b   Ho, Yuan Shing ^f   Kuo, Fu Wen ^b   Lu, Mei Chin ^a,b  

^a NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^b NATIONAL MUSEUM OF MARINE BIOLOGY AND AQUARIUM   (Taiwan)

^c Department of Nutrition   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e African Union Organization St Abbassia   (Egypt)

^f FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

10 acetylirciformonin B; Apoptosis; DNA damage; Sponge

Indexed keywords

10 ACETYLIRCIFORMONIN B; 10-ACETYLIRCIFORMONIN B; ANTINEOPLASTIC AGENT; CASPASE; TERPENE;

ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CHEMISTRY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; HUMAN; IC 50; METABOLISM; SIGNAL TRANSDUCTION; SPONGE (PORIFERA);

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL PROLIFERATION; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; PORIFERA; SIGNAL TRANSDUCTION; TERPENES;

EID: 84868140756     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171011839     Document Type: Article

References (21)

1. D'Autréaux, B.; Toledano, M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8, 813-824.
2. Fruehauf, J.P.; Meyskens, F.L., Jr. Reactive oxygen species: A breath of life or death? Clin. Cancer Res. 2007, 13, 789-794.
3. Chen, H.M.; Wu, Y.C.; Chia, Y.C.; Chang, F.R.; Hsu, H.K.; Hsieh, Y.C.; Chen, C.C.; Yuan, S.S. Gallic acid, A major component of Toona sinensis leaf extracts, Contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett. 2009, 286, 161-171.
4. Havsteen, B. Flavonoids, A class of natural products of high pharmacological potency. Biochem. Pharmacol. 1983, 32, 1141-1148.
5. Mroz, R.M.; Schins, R.P.F.; Li, H.; Jimenez, L.A.; Drost, E.M.; Holownia, A.; MacNee, W.; Donaldson, K. Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. Eur. Respir. J. 2008, 31, 241-251.
6. Brem, R.; Montaner, B.; Reelfs, O.; Karran, P. DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation. Oncogene 2010, 29, 3953-3963.
7. Ha, L.; Ceryak, S.; Patierno, S.R. Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX. Carcinogenesis 2004, 25, 2265-2274.
8. Powell, S.N.; Bindra, R.S. Targeting the DNA damage response for cancer therapy. DNA Repair 2009, 8, 1153-1165.
9. Chen, H.M.; Chang, F.R.; Hsieh, Y.C.; Cheng, Y.J.; Hseih, K.C.; Tsai, L.M.; Lin, A.S.; Wu, Y.C.; Yuan, S.S. A novel synthetic protoapigenone analogue, WYC02-9, Induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species. Free Radic. Biol. Med. 2011, 50, 1151-1162.
10. Kastan, M.B.; Lim, D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 2000, 1, 179-186.
11. Bakkenist, C.J.; Kastan, M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421, 499-506.
12. Abraham, R.T.; Tibbetts, R.S. Guiding ATM to broken DNA. Science 2005, 308, 510-511.
13. Bulavin, D.V.; Higashimoto, Y.; Demidenko, Z.N.; Meek, S.; Graves, P.; Phillips, C.; Zhao, H.; Moody, S.A.; Apella, E.; Piwnica-Worms, H.; et al. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat. Cell Biol. 2003, 5, 545-551.
14. Jang, E.R.; Choi, J.D.; Park, M.A.; Jeong, G.; Cho, H.; Lee, J.S. ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response. Exp. Mol. Med. 2010, 42, 195-204.
15. Skropeta, D.; Pastro, N.; Zivanovic, A. Kinase inhibitors from marine sponges. Mar. Drugs 2011, 9, 2131-2154.
16. Koopmans, M.; Martens, D.; Wijffels, R.H. Towards commercial production of sponge medicines. Mar. Drugs 2009, 7, 787-802.
17. Mohapatra, B.R.; Bapuji, M.; Sree, A. Antifungal efficacy of bacteria isolated from marine sedentary organisms. Folia Microbiol. 2002, 47, 51-55.
18. Li, D.; Xu, Y.; Shao, C.L.; Yang, R.Y.; Zheng, C.J.; Chen, Y.Y.; Fu, X.M.; Qian, P.Y.; She, Z.G.; de Voogd, N.J.; et al. Antibacterial Bisabolane-Type Sesquiterpenoids from the Sponge-Derived Fungus Aspergillus sp. Mar. Drugs 2012, 10, 234-241.
19. Ohno, O.; Suenaga, K.; Uemura, D. Secondary metabolites with new medicinal functions from marine organisms. Adv. Food Nutr. Res. 2012, 65, 185-193.
20. Su, J.H.; Tseng, S.W.; Lu, M.C.; Liu, L.L.; Chou, Y.; Sung, P.J. Cytotoxic C21 and C22 terpenoid-derived metabolites from the sponge Ircinia sp. J. Nat. Prod. 2011, 74, 2005-2009.
21. Yang, H.L.; Hseu, Y.C.; Chen, J.Y.; Yech, Y.J.; Lu, F.J.; Wang, H.H.; Lin, P.S.; Wamg, B.C. Antrodia camphorata in submerged culture protects low density lipoproteins against oxidative modification. Am. J. Chin. Med. 2006, 34, 217-231.